xAmplification - Company News in Context

Live

101–160 of 160 articles · filtered by Healthcare & Biotech

Capricor Therapeutics (CAPR) Stock Skyrockets on HOPE‑3 Win: FDA Path, Price Targets and 2026 Outlook - TechStock²

Mining|Bullish|3 Dec 2025 · 3 months ago

66 Top Healthcare Startups and Healthtech Companies

Mining|Bullish|2 Dec 2025 · 3 months ago

Tiny Biotech’s Big Bet On Rare Skin Diseases

Mining|Bullish|1 Dec 2025 · 3 months ago

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?

Mining|Bullish|30 Nov 2025 · 3 months ago

2 No-Brainer Healthcare Stocks to Buy Now

Mining|Bullish|18 Nov 2025 · 3 months ago

Moleculin Biotech Bets Big On New Cancer Drug Trials

Mining|Bullish|15 Nov 2025 · 4 months ago

Australian biotech firm Heidi joins overseas peers in setting up Hong Kong base

Mining|Bullish|13 Nov 2025 · 4 months ago

Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook - TechStock²

Mining|Bullish|5 Nov 2025 · 4 months ago

Top Biotech Stocks Riding The Rally

Mining|Bullish|4 Nov 2025 · 4 months ago

hVIVO plc (AIM: HVO) Presentation at Jefferies Healthcare Conference

HVO|Bullish|3 Nov 2025 · 4 months ago

Which Healthcare Giant Could Outshine on the ASX in 2025?

Mining|Bullish|31 Oct 2025 · 4 months ago

Inside Biotech: CSL’s vaccine stumble wipes billions from healthcare heavyweights

Mining|Bearish|28 Oct 2025 · 4 months ago

BridgeBio aces phase 3 rare disease test, clearing path to FDA

Mining|Bullish|27 Oct 2025 · 4 months ago

StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market - GEN

Mining|Bullish|26 Oct 2025 · 4 months ago

Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash? - TechStock²

Mining|Bearish|24 Oct 2025 · 4 months ago

Biotech & Pharma Q2 2025: AI Innovations, M&A Moves, and Policy Challenges Unveiled

Mining|Bullish|23 Oct 2025 · 4 months ago

BlackRock’s Big Bet Sends SELLAS Life Sciences (SLS) Stock Soaring – What’s Next for This Biotech? - TechStock²

Mining|Bullish|18 Oct 2025 · 5 months ago

Femasys (FEMY) Rockets on Fertility Breakthroughs and FDA Milestones – What’s Behind the Surge? - TechStock²

Mining|Bullish|17 Oct 2025 · 5 months ago

Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer? - TechStock²

Mining|Bullish|17 Oct 2025 · 5 months ago

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors? - TechStock²

Mining|Bullish|17 Oct 2025 · 5 months ago

MIRA Pharma Stock Skyrockets 100% Overnight as New Pain Drug Outshines Morphine - TechStock²

Mining|Bullish|16 Oct 2025 · 5 months ago

Adaptimmune Stock’s Wild 2025 Ride: Speculative Surge or True Biotech Comeback? - TechStock²

Mining|Bullish|9 Oct 2025 · 5 months ago

Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA

Mining|Bullish|8 Oct 2025 · 5 months ago

Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real? - TechStock²

Mining|Bullish|8 Oct 2025 · 5 months ago

No-Revenue Biotech Soars 64,000% – Is Regencell (RGC) a Breakthrough or a Bubble? - TechStock²

Mining|Bearish|7 Oct 2025 · 5 months ago

Galecto Stock Skyrockets 600% – Short Squeeze Mania or Biotech Breakthrough? - TechStock²

Mining|Neutral|7 Oct 2025 · 5 months ago

Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough – Inside the Stock Surge, Pipeline & Outlook (Oct 2025) - TechStock²

Mining|Bullish|7 Oct 2025 · 5 months ago

Spruce Biosciences Skyrockets on FDA Breakthrough – Will SPRB’s Rally Last or Fade? - TechStock²

Mining|Bullish|6 Oct 2025 · 5 months ago

Dr Boreham’s Crucible: 4D Medical enters crucial US dimension with high hopes

Mining|Bullish|30 Sep 2025 · 5 months ago

Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update - TechStock²

Mining|Bullish|26 Sep 2025 · 5 months ago

1 Small-Cap Biotech Stock Poised for a Breakout

Mining|Bullish|11 Sep 2025 · 6 months ago

A Look at Celcuity (CELC) Valuation After FDA Review Triggered by VIKTORIA-1 Breast Cancer Trial Results

Mining|Bullish|9 Sep 2025 · 6 months ago

A UK biotech takes aim at Parkinson’s, ALS by drugging mitochondria

Mining|Bullish|8 Sep 2025 · 6 months ago

Hoth Therapeutics (NASDAQ: HOTH): Small-Cap Biotech Pairing Clinical Breakthroughs with AI Innovation

HOTH|Neutral|8 Sep 2025 · 6 months ago

A Micropatch. A Urology Pipeline. Why Medicus Pharma (NASDAQ:MDCX) Could Be the Biotech Story of the Year

MDCX|Neutral|7 Sep 2025 · 6 months ago

HealthInvest returns, with top ASX healthcare talent

Mining|Bullish|3 Sep 2025 · 6 months ago

Sagimet Gains Momentum As FDA Eases Path For MASH Drug Development (NASDAQ:SGMT)

SGMT|Bullish|29 Aug 2025 · 6 months ago

2 Small-Cap Biotech Stocks Well Positioned for a Breakout

Mining|Neutral|27 Aug 2025 · 6 months ago

Here are 5 ASX biotechs expecting clinical trial results in the next few months!

Mining|Neutral|27 Aug 2025 · 6 months ago

Parallel Bio’s $21M in Series A will drive aim to trim $2B and 9 years from drug development timelines

Mining|Bullish|17 Jun 2025 · 9 months ago

How 3 Hong Kong health and biotech start-ups aim to help improve the lives of millions

Mining|Bullish|4 Jun 2025 · 9 months ago

With fine-tuned AI models, OpenAI, Babylon aim to predict clinical trial successes

Mining|Bullish|14 May 2025 · 10 months ago

ASX medtechs at the forefront of precision, safety and efficiency in healthcare

Mining|Bullish|28 Apr 2025 · 10 months ago

Health is wealth: A financial breakdown of 160+ ASX-listed healthcare leaders

Mining|Bullish|4 Apr 2025 · 11 months ago

DIAGNOS is filing for the Saudi FDA Authorization of Its CARA SYSTEM, an AI Assisted Medical Device

Mining|Bullish|12 Mar 2025 · 12 months ago

AIM Vaccine submits mRNA RSV vaccine for FDA clinical trials - News

Mining|Bullish|10 Feb 2025 · about 1 year ago

Nvidia partnerships aim to accelerate use of AI agents in healthcare research

Mining|Neutral|13 Jan 2025 · about 1 year ago

Biotech firms aim for Kosdaq listing amid challenging market conditions

Mining|Bullish|3 Jan 2025 · about 1 year ago

Biotech startup Lamassu, Cleveland Clinic aim to treat rare cancers with just three pills a month

Mining|Bullish|4 Nov 2024 · over 1 year ago

Three startups aim to raise $400 mln as US biotech IPOs gain traction

Mining|Bullish|7 Oct 2024 · over 1 year ago

UK biotech ReNeuron quits AIM as financing push fails

Mining|Bearish|30 Aug 2024 · over 1 year ago

The 3 Best Neuroscience Biotech Stocks to Buy Now

Mining|Bullish|19 Jul 2024 · over 1 year ago

e-therapeutics is latest UK biotech to seek AIM de-listing

Mining|Bearish|10 Apr 2024 · almost 2 years ago

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

Mining|Bullish|25 Feb 2024 · about 2 years ago

Cour Pharmaceuticals, a biotech taking aim at autoimmune diseases, raises $105 million

Mining|Bullish|30 Jan 2024 · about 2 years ago

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

Mining|Bullish|16 Dec 2023 · about 2 years ago

6 Best Healthcare Stocks to Buy Right Now

Mining|Bullish|25 Apr 2023 · almost 3 years ago

The delisting dilemma: Why do so many biotechs face being kicked off the Nasdaq?

Mining|Bearish|14 Mar 2023 · almost 3 years ago

Small biotech Accera reinvents itself, takes aim at Alzheimer’s treatment

Mining|Bullish|8 Jun 2016 · over 9 years ago

India's drug discovery and development: Small research firms aim to change face of cancer therapy

Mining|Neutral|8 May 2014 · almost 12 years ago

← Prev12Next →